July 09, 2014 10:54 PM ET

Pharmaceuticals

Company Overview of Takeda GmbH

Company Overview

Takeda GmbH, through its subsidiaries, is engaged in the research and development, manufacture, and sales of patented products, branded generics, and over-the-counter products. It offers diabetes treatment pioglitazone hydrochloride tables that improve insulin sensitivity and reduces blood glucose levels; diabetes treatment alogliptin benzoate that lowers blood glucose levels; Candesartan cilexetil, an angiotensin II receptor blocker for hypertension treatment; Azilsartan, a angiotensin II receptor blocke; and omega-3-acid ethyl esters. The company provides products on various therapeutic areas that include cardiovascular and metabolic, oncology, central nervous system, respiratory and immun...

Byk-Gulden-Str. 2

Constance,  78467

Germany

Founded in 1873

Phone:

49 7531 84 0

Fax:

49 7531 84 2474

Key Executives for Takeda GmbH

Chief Executive Officer
Age: 64
Research & Development Head and Member of Management Board
Age: 54
Human Resources & Information Technology Head and Member of the Board of Management
Age: 58
Vice President of Clinical and Scientific Affairs
Finance & Operations Head and Member of The Board of Management
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Tinnitus Forschungs und Entwicklungs GmbH Europe
Innosis Ecological AG Europe
ElexoPharm GmbH Europe
Dr. Falk Pharma GmbH Europe
Averion GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Takeda GmbH, please visit www.takeda.de/de. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.